Increased expression of the interleukin-36 cytokines in lesions of hidradenitis suppurativa

J Eur Acad Dermatol Venereol. 2017 Dec;31(12):2091-2096. doi: 10.1111/jdv.14389. Epub 2017 Aug 29.

Abstract

Background: Hidradenitis suppurativa (HS) is a recalcitrant chronic skin disease with poorly understood immunopathogenic mechanisms. Previous studies reported that the interleukin-36 (IL-36) cytokines [IL-36α, IL-36β, IL-36γ and IL-36 receptor antagonists (IL-36RA)] are important players in the pathogenesis of psoriasis (PS).

Objective: We aim to determine whether the IL-36 cytokines are upregulated in patients with HS. For this purpose, we analysed local expression and systemic levels of the IL-36 cytokines in patients with HS and compared the results to healthy donors and patients with PS.

Methods: Skin biopsies from healthy donors and HS and PS patients were analysed for expression of the IL-36 cytokines by immunohistochemistry and semiquantitative real-time PCR. The enzyme-linked immunosorbent assay (ELISA) was used to measure systemic levels of the IL-36 cytokines in the serum of the three donor groups.

Results: The agonists IL-36α, IL-36β and IL-36γ were found to be upregulated in HS both systemically and lesionally, while the IL-36RA was not differently regulated in comparison to healthy donors.

Conclusion: Our findings suggest that the agonistic IL-36 isoforms are upregulated in HS. The relevance of the enhanced production of IL-36 cytokines in HS pathogenesis remains to be determined.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Hidradenitis Suppurativa / metabolism*
  • Humans
  • Interleukin-1 / biosynthesis*
  • Interleukins / biosynthesis*
  • Male
  • Middle Aged
  • Up-Regulation
  • Young Adult

Substances

  • IL36A protein, human
  • IL36B protein, human
  • IL36G protein, human
  • IL36RN protein, human
  • Interleukin-1
  • Interleukins